Amgen (NASDAQ: AMGN) EVP uses 556 shares to cover tax obligations

Rhea-AI Filing Summary

Amgen Inc. executive David M. Reese reported a routine tax-related share disposition. On 2026-05-07, 556 shares of Amgen common stock were withheld at $331.11 per share to satisfy tax obligations associated with equity compensation. After this withholding, he directly holds 42,256 shares of Amgen common stock. A footnote also notes 350 Dividend Equivalents tied to unvested Restricted Stock Units that will pay out in shares as they vest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider REESE DAVID M

Role EVP & Chief Technology Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	556	$331.11	$184K

Holdings After Transaction: Common Stock — 42,256 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 556 shares Withholding price: $331.11 per share Post-transaction holdings: 42,256 shares +1 more

4 metrics

Tax-withholding shares 556 shares Common stock withheld on 2026-05-07 for tax obligations

Withholding price $331.11 per share Price applied to 556 shares used to satisfy tax liability

Post-transaction holdings 42,256 shares Direct Amgen common stock held by David M. Reese after transaction

Dividend Equivalents 350 DEs Credited to unvested RSUs under Amgen 2009 Equity Incentive Plan

Key Terms

Dividend Equivalents (DEs), Restricted Stock Units, Equity Incentive Plan, tax-withholding disposition

4 terms

Dividend Equivalents (DEs) financial

"These shares include 350 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

REESE DAVID M

(Last) (First) (Middle)

ONE AMGEN CENTER

DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		F		556	D	$331.11	42,256(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 350 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ David M. Reese	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Amgen (AMGN) executive David M. Reese report in this Form 4?

David M. Reese reported a tax-withholding disposition of 556 Amgen common shares. The shares were withheld to cover tax liabilities tied to his equity compensation, a standard administrative transaction rather than an open-market sale or purchase.

How many Amgen (AMGN) shares were involved in David M. Reese’s tax withholding?

The transaction involved 556 shares of Amgen common stock at $331.11 per share. These shares were delivered to cover tax obligations, consistent with the Form 4 code F for payment of tax liability by surrendering securities.

How many Amgen (AMGN) shares does David M. Reese hold after this Form 4 transaction?

Following the tax-withholding disposition, David M. Reese directly holds 42,256 Amgen shares. This post-transaction balance reflects his remaining equity stake after 556 shares were used to satisfy tax obligations related to his compensation.

Was David M. Reese’s Amgen (AMGN) Form 4 an open-market sale of shares?

No. The Form 4 shows a tax-withholding disposition coded F, meaning 556 shares were surrendered to pay tax liabilities. This is not an open-market sale and does not represent discretionary selling in the public market.

What are Dividend Equivalents (DEs) mentioned in David M. Reese’s Amgen (AMGN) filing?

The footnote states that 350 Dividend Equivalents are credited to his unvested Restricted Stock Units. These DEs are paid out in Amgen common shares on a one-to-one basis as the RSUs vest, plus cash for any remaining fractional share.

Which Amgen (AMGN) equity plan governs David M. Reese’s Dividend Equivalents and RSUs?

The Dividend Equivalents are granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. They are tied to unvested Restricted Stock Units and follow the plan’s vesting and dividend reinvestment provisions described in the Form 4 footnote.